US2007010676A1PendingUtilityA1
Stereospecific enrichment of heterocyclic enantiomers
Est. expiryOct 25, 2021(expired)· nominal 20-yr term from priority
C07B 2200/07Y02P20/582C07D 215/36
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention describes methods for the stereoselective synthesis of heterocyclic enantiomers. The methods of the present invention incorporate the stereo-preferred oxidation of quinolone thiomethyl intermediates by optically active camphor based oxaziridines to provide R(+) or S(−) quinolone methylsulfinyl derivatives.
Claims
exact text as granted — not AI-modified1 . A method, comprising:
a) providing: i) a flosequinan racemate; ii) triphenylphosphine; and b) reacting, in a solvent, said flosequinan racemate with said triphenylphosphine under conditions such that a racemic mixture of 7-fluoro-1-methyl-3-methylthio-4-quinolone is produced.
2 . The method of claim 1 , wherein said solvent is selected from the group consisting of carbon tetrachloride and a mixture of xylene and carbon tetrabromide.
3 . The method of claim 1 , further comprising:
c) treating said racemic mixture of 7-fluoro-1-methyl-3-methylthio-4-quinolone with (1R)-(−)-(10-camphorsulfonyl)oxaziridine under conditions such that R-(+)-flosequinan is produced in enantiomeric excess.
4 . A method, comprising:
a) providing: i) a flosequinan racemate; ii) triphenylphosphine; and b) reacting, in a solvent, said flosequinan racemate with said triphenylphosphine under conditions such that a racemic mixture of 7-fluoro-1-methyl-3-methylthio-4-quinolone is produced. c) treating said racemic mixture of 7-fluoro-1-methyl-3-methylthio-4-quinolone with (1S)-(+)-(10-camphorsulfonyl)oxaziridine under conditions such that S-(−)-flosequinan is produced in enantiomeric excess.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.